Outset Medical, Inc. OM 深 沪
等待开盘 02-11 09:30:00 美东时间
4.70
+0.050
+1.08%
华盛通- 最 高4.9212
- 今 开4.68
- 成交量 18.60万股
- 最 低 4.635
- 昨 收 4.65
- 总市值 8531.95万
- 52周最高 21.98
- 市盈率 静 --
- 换手率 1.02%
- 52周最低 3.10
- 委 比 98.25%
- 总股本 1815.31万
- 历史最高 978.45
- 量 比 0.65
- 振 幅 6.15%
- 历史最低 3.625
- 每 手 1
- 风险率 5.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Outset Medical Gets FDA's Clearance For Its Tablo Platform
Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced 510(k) clearance by the
01-27 22:06
美股牛股 | 私人航空公司UP单日暴涨46%！One Stop大涨29%，获美军预生产订单
私人航空公司UP单日暴涨46%！One Stop股价涨29%，获美军预生产订单；BIOA涨逾27%，核心在研药获突破进展>>
01-13 17:24
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
Stifel Maintains Buy on Outset Medical, Lowers Price Target to $8
Stifel analyst Rick Wise maintains Outset Medical (NASDAQ:OM) with a Buy and lowers the price target from $14 to $8.
01-07 22:19
Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
Outset Medical, Inc. announced that its Chair & CEO, Leslie Trigg, will present at the J.P. Morgan Healthcare conference on January 14, 2026. The presentation will be available live and archived on the company’s investor website. Outset, a medical tech company, has developed the Tablo® Hemodialysis System, FDA-cleared for use from hospitals to homes, reducing the cost and complexity of dialysis. The system is trusted by over 1,000 U.S. healthcare...
01-05 21:05
美股大行评级 | 潜在涨幅263.64%！Milestone Pharmaceuticals获富国银行升目标价至8美元，维持"超配"评级
今日重点评级关注：富国银行：维持Milestone Pharmaceuticals"超配"评级，目标价从4美元升至8美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从31美元升至33美元
2025-12-17 10:46
BTIG Reiterates Buy on Outset Medical, Maintains $17 Price Target
BTIG analyst Marie Thibault reiterates Outset Medical (NASDAQ:OM) with a Buy and maintains $17 price target.
2025-12-16 18:55
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
2025-11-12 11:43
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers MSP Recovery (NASDAQ:MSPR) shares rose 93.0% to $0.61 during Tuesday's...
2025-11-11 20:07
Why Rocket Lab Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Shares of Rocket Lab Corp (NASDAQ:RKLB) rose sharply in pre-market trading afte...
2025-11-11 18:55
